WEALTH ENHANCEMENT ADVISORY SERVICES, LLC

Position in HALO — Halozyme Therapeutics, Inc.

CIK 1632972 PLYMOUTH, MN

Position in HALO

as of Jun 30, 2026 · filed Jul 15, 2026 Compact

Position Value

$5,541,281

+$2,525,323 QoQ

Shares Held

70,797

+51.7% QoQ

Ownership

0.060%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

of 58 holders

Holding Since

Sep 2023

11 quarters on record

Voting authority Sole 1.0734918146249135.ToString("F0")% Shared 0.ToString("F0")% None 98.92650818537508.ToString("F0")%

Healthcare · as of Jun 30, 2026

WEALTH ENHANCEMENT ADVISORY SERVICES, LLC holds $166,117,226 across 147 Biotechnology names. HALO ranks #7 (3.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	45,889	$22,794,442
2	REGN	Regeneron Pharmaceuticals, Inc.	33,880	$21,125,535
3	INCY	Incyte Corp	151,505	$17,174,606
4	EXEL	Exelixis, Inc.	207,728	$11,302,480
5	RPRX	Royalty Pharma plc	179,888	$10,086,320
6	CORT	Corcept Therapeutics Inc	76,278	$6,632,372
7	HALO	Halozyme Therapeutics, Inc. This page	70,797	$5,541,281
8	AXSM	Axsome Therapeutics, Inc.	19,919	$4,875,573

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$5,541,281	70,797	+51.7%	Shares	Sole	2026-07-15
2026-03-31	$3,015,958	46,665	+120.3%	Shares	Sole	2026-04-08
2025-12-31	$1,425,817	21,186	-0.0%	Shares	Sole	2026-01-08
2025-09-30	$1,554,221	21,192	+49.5%	Shares	Sole	2025-10-29
2025-06-30	$737,175	14,171	-31.9%	Shares	Sole	2025-07-10
2025-03-31	$1,328,524	20,820	+66.8%	Shares	Sole	2025-04-16
2024-12-31	$596,620	12,479	+7.5%	Shares	Sole	2025-03-17
2024-09-30	$664,556	11,610	-1.4%	Shares	Sole	2024-10-24
2024-06-30	$616,329	11,771	+15.2%	Shares	Sole	2024-07-16
2024-03-31	$415,627	10,217	+6.4%	Shares	Sole	2024-04-15
2023-09-30	$366,949	9,606	—	Shares	Sole	2023-11-13
No filing history on record for this holder in this stock.